Studies have shown that active fund managers routinely underperform the S&P500 index*​

GSK plc (NYSE: GSK)

GSK Stock Predictions and Ratings

WSX Rating:
BUY
WSX Forecast (1yr):
15.10%
Analyst Rating:
BUY
Analyst Forecast (1yr):
NOT AVAILABLE

GSK Stock Analysis

GSK PE Ratio: 13.1

GSK PEG Ratio: 1.6

GSK Forward EPS Growth (12 month): 8.40%

GSK PS Ratio: 2.3

GSK PSG Ratio: 0.5

GSK Forward Revenue Growth (12 month): 4.30%

GSK Articles

No data was found